Kunder, Rebecca
30  Ergebnisse:
Personensuche X
?
1

Simulation‐based evaluation of personalized dosing approach..:

Yoshida, Kenta ; Poon, Victor ; Dash, Ajit...
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  4 - p. 544-550 , 2024
 
?
3

Utilizing PK and PD Biomarkers to Guide the First-in-Human ..:

Yadav, Rajbharan ; Sukumaran, Siddharth ; Lutman, Jeff...
Journal of Pharmaceutical Sciences.  112 (2023)  11 - p. 2910-2920 , 2023
 
?
4

First‐in‐human phase 1 trial evaluating safety, pharmacokin..:

Tang, Fei ; Kunder, Rebecca ; Chu, Tom...
Clinical and Translational Science.  16 (2023)  9 - p. 1653-1666 , 2023
 
?
6

Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric..:

Chen, Hubert ; Kunder, Rebecca ; Zou, Yixuan...
Pulmonary Pharmacology & Therapeutics.  75 (2022)  - p. 102133 , 2022
 
?
11

First‐in‐human phase 1 trial evaluating safety, pharmacokin..:

Tang, Fei ; Kunder, Rebecca ; Chu, Tom...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499406/.  , 2023
 
?
12

T cell co-stimulatory factors:Crossing the minefield betwee..:

Greisen, Stinne ; Kunder, Rebecca ; Deleuran, Bent
https://pure.au.dk/portal/da/publications/t-cell-costimulatory-factors(9052d79a-38fd-4bb1-a018-30ad75b82f06).html.  , 2017
 
1-15